“Cholesterol control and the achievement of target values are the most effective weapons to reduce cardiovascular mortality and significantly improve the quality of life of patients and their families. “He highlighted this Furio Colivicchi, president of the National Association of Hospital Cardiologists (Anmco) taking part in the event “New cardiovascular prevention strategies in the post-pandemic: the challenge starts from the territory”.
“In recent years – he recalled – hypercholesterolemia has shown a worrying growth trend. A phenomenon that is combined with the worrying fact that 80% of high-risk patients do not reach the optimal Ldl level recommended by the guidelines for treatment with statins alone, putting them at risk of incurring cardiovascular events or death. Hypercholesterolemia, combined with an increase in the body mass index – he concluded – represents a time bomb for unforeseen acute events“.